Research location
Cuyahoga Falls
Ohio, United States
Advertisement
Research activity in Cuyahoga Falls
Ohio, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Cuyahoga Falls
9 linked trials · page 1 of 1The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) StudyNCT03152292 · 2017-03-30 · 1 site observation
TERMINATED
Safety and Efficacy Study of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of MetforminNCT00850239 · 2009-05-01 · 1 site observation
TERMINATED
Colesevelam as Add-on to Pioglitazone Therapy for Type 2 Diabetes MellitusNCT00789750 · 2009-04-01 · 1 site observation
COMPLETED
Welchol as Monotherapy for Type 2 Diabetes MellitusNCT00789737 · 2009-01-01 · 1 site observation
COMPLETED
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes MellitusNCT00700817 · 2008-06-01 · 1 site observation
COMPLETED
A Clinical Study to Evaluate the Use of Episodic, Intensive Blood Glucose Monitoring in Persons With Non-insulin Treated Type 2 DiabetesNCT00674986 · 2008-03-01 · 1 site observation
COMPLETED
A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active ComparatorNCT00631007 · 2008-02-01 · 1 site observation
COMPLETED
Safety and Efficacy Study in Subjects With Diabetic Neuropathic PainNCT00507936 · 2007-08-01 · 1 site observation
COMPLETED
Naturlose (D-Tagatose) Efficacy Evaluation TrialNCT00955747 · 2007-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.